# Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC

> **NCT00162708** · PHASE2,PHASE3 · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 120 (—)

## Conditions studied

- Oropharynx Cancer
- Oral Cancer
- Hypopharynx Cancer
- Larynx Cancer

## Interventions

- **PROCEDURE:** Radiotherapy 62-64 Gy in 5 W (31-32 f. of 2 Gy BID)
- **PROCEDURE:** Radiotherapy 62-64 Gy in 22-23 D (31-32 f of 2 Gy BID)
- **DRUG:** CDDP, 5 Fu

## Key facts

- **NCT ID:** NCT00162708
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 120 (—)
- **Last updated:** 2005-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162708, "Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00162708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*